A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier
- 31 October 2001
- journal article
- Published by Elsevier in Biomaterials
- Vol. 23 (9) , 1981-1987
- https://doi.org/10.1016/s0142-9612(01)00325-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Oral fluoropyrimidines in the treatment of colorectal cancerEuropean Journal Of Cancer, 1998
- Tumor Selective Delivery of 5-Fluorouracil by Capecitabine, a New Oral Fluoropyrimidine Carbamate, in Human Cancer XenograftsBiochemical Pharmacology, 1998
- Adsorption of alachlor by montmorillonitesJournal of Thermal Analysis and Calorimetry, 1997
- Colorectal cancer—Is there an alternative to 5-FU?European Journal Of Cancer, 1997
- Doxifluridine in colorectal cancer patients resistant to 5-fluorouracil (5-FU) containing regimensEuropean Journal Of Cancer, 1997
- Neutron Diffraction Study of Interlayer Water in Sodium Wyoming Montmorillonite Using a Novel Difference MethodClays and Clay Minerals, 1997
- Effect of non-swelling layers on the dissolution of reduced-charge montmorillonite in hydrochloric acidClay Minerals, 1996
- Preparation and characterization of PMMA-clay hybrid composite by emulsion polymerizationJournal of Applied Polymer Science, 1996
- An overview of adjuvant therapy for colorectal cancerEuropean Journal Of Cancer, 1995
- Attenuating organic contaminant mobility by soil modificationNature, 1988